Lurbinectedin Monotherapy in Participants With Advanced or Metastatic Solid Tumors

Clinical trial NCT05126433 · TERMINATED

Trial details

NCT number: NCT05126433
Sponsor: Jazz Pharmaceuticals
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor Metastatic Solid Tumor Urothelial Cancer Poorly Differentiated Neuroendocrine Carcinomas Homologous Recombination Deficient-Positive Malignancies Agnostic

Start date: 2022-03-03
Primary completion: 2023-12-20
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.